Literature DB >> 16410536

Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseases.

Y Munakata, T Saito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16410536      PMCID： PMC1798017          DOI： 10.1136/ard.2005.038653

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Clinical manifestations of human parvovirus B19 in adults.

Authors:  A D Woolf; G V Campion; A Chishick; S Wise; B J Cohen; P T Klouda; O Caul; P A Dieppe
Journal:  Arch Intern Med       Date:  1989-05

Review 3.  Parvovirus B19 infection and autoimmune disease.

Authors:  Hartwig W Lehmann; Philipp von Landenberg; Susanne Modrow
Journal:  Autoimmun Rev       Date:  2003-06       Impact factor: 9.754

4.  Parvovirus infection suppresses long-term repopulating hematopoietic stem cells.

Authors:  José C Segovia; Guillermo Guenechea; Jesús M Gallego; José M Almendral; Juan A Bueren
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction.

Authors:  Takako Saito; Yasuhiko Munakata; Yi Fu; Hiroshi Fujii; Takao Kodera; Eiji Miyagawa; Keiko Ishii; Takeshi Sasaki
Journal:  J Virol Methods       Date:  2003-01       Impact factor: 2.014

6.  Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis.

Authors:  B Harrison; A Silman; E Barrett; D Symmons
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

7.  Human parvovirus B19 as a causative agent for rheumatoid arthritis.

Authors:  Y Takahashi; C Murai; S Shibata; Y Munakata; T Ishii; K Ishii; T Saitoh; T Sawai; K Sugamura; T Sasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

9.  Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

Authors:  Lutz Liefeldt; Annelie Plentz; Boris Klempa; Olivia Kershaw; Anne-Sophie Endres; Ulla Raab; Hans-H Neumayer; Helga Meisel; Susanne Modrow
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.